Author

Bo Xie

Institution: General Hospital of Guangzhou Military Command

Observed institutions: Guangzhou University of Chinese Medicine, General Hospital of Guangzhou Military Command

OpenAlex ID: A5062275099

Efficacy and Safety of KL-A167 in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Single-Arm, Phase 2 Study

2022 · Yuankai Shi, Xintian Qin, et al. · The Lancet Regional Health - Western Pacific · 29

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial

2026 · Yan Huang, Dongchen Sun, et al. · JAMA Oncology · 15

TTF-1 expression stratifies chemoimmunotherapy benefits in PD-L1-negative lung adenocarcinoma: a real-world biomarker validation

2025 · Ning Yang, Lijuan Xiong, et al. · Journal of Thoracic Disease

Works count: 3

Citation count: 44

H-index: 2

I10-index: 2